Income Taxes (Tables)
|
12 Months Ended |
Mar. 31, 2026 |
| Income Tax Disclosure [Abstract] |
|
| Schedule of Income before Income Tax, Domestic and Foreign |
The components of our income (loss) prior to income taxes were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended March 31, |
|
2026 |
|
2025 |
|
2024 |
| U.S. |
$ |
(49,887) |
|
|
$ |
(109,128) |
|
|
$ |
(170,057) |
|
| Foreign |
18,547 |
|
|
21,264 |
|
|
(235,074) |
|
| Loss before income taxes |
$ |
(31,340) |
|
|
$ |
(87,864) |
|
|
$ |
(405,131) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Schedule of Provision (Benefit) for Income Taxes |
The components of the Company’s income tax provision (benefit) attributable to operations are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended March 31, |
|
|
2026 |
|
2025 |
|
2024 |
| Current: |
|
|
|
|
|
|
| U.S. federal |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
| State and local |
|
— |
|
|
— |
|
|
— |
|
| Foreign |
|
6,739 |
|
|
8,241 |
|
|
8,262 |
|
|
|
6,739 |
|
|
8,241 |
|
|
8,262 |
|
| Deferred: |
|
|
|
|
|
|
| U.S. federal |
|
(8) |
|
|
(9) |
|
|
5,925 |
|
| State and local |
|
(3) |
|
|
— |
|
|
5,491 |
|
Foreign |
|
(336) |
|
|
(3,997) |
|
|
(4,361) |
|
|
|
(347) |
|
|
(4,006) |
|
|
7,055 |
|
| Income tax expense |
|
$ |
6,392 |
|
|
$ |
4,235 |
|
|
$ |
15,317 |
|
|
| Schedule of Reconciliation of Income Tax Expense Between Statutory U S Income Tax Rate With Actual Income Tax Provision |
A reconciliation of the U.S. federal statutory income tax rate to our effective tax rate pursuant to the disclosure requirements of ASU 2023-09 for the year ended March 31, 2026 was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended March 31, 2026 |
|
|
Amount |
|
Percent |
| U.S. federal statutory tax rate |
|
$ |
(6,581) |
|
|
21.0 |
% |
| State and local income taxes, net of federal income tax effect |
|
(3) |
|
|
— |
% |
| Foreign tax effects |
|
|
|
|
| Israel |
|
|
|
|
| Statutory tax rate difference between Israel and U.S. |
|
(3,630) |
|
|
11.6 |
% |
| Other |
|
96 |
|
|
(0.3) |
% |
| Germany |
|
|
|
|
| Statutory tax rate difference between Germany and U.S. |
|
(1,650) |
|
|
5.3 |
% |
| Changes in valuation allowance |
|
7,318 |
|
|
(23.4) |
% |
| Deferred tax rate remeasurement |
|
(2,016) |
|
|
6.4 |
% |
| Other |
|
62 |
|
|
(0.2) |
% |
| Brazil |
|
|
|
|
| Changes in valuation allowance |
|
1,076 |
|
|
(3.4) |
% |
| Return to provision |
|
336 |
|
|
(1.1) |
% |
| Other |
|
(241) |
|
|
0.8 |
% |
| Luxembourg |
|
|
|
|
| Return to provision |
|
375 |
|
|
(1.2) |
% |
| Other |
|
(369) |
|
|
1.2 |
% |
| Netherlands |
|
|
|
|
| Changes in valuation allowance |
|
513 |
|
|
(1.6) |
% |
| Other |
|
(103) |
|
|
0.3 |
% |
| Norway |
|
|
|
|
| Changes in valuation allowance |
|
390 |
|
|
(1.2) |
% |
| Other |
|
(218) |
|
|
0.7 |
% |
| Singapore |
|
|
|
|
| Changes in valuation allowance |
|
1,035 |
|
|
(3.3) |
% |
| Return to provision |
|
(441) |
|
|
1.4 |
% |
| Other |
|
22 |
|
|
(0.1) |
% |
| Other Foreign Jurisdictions |
|
(114) |
|
|
0.4 |
% |
| Tax credits |
|
|
|
|
| Research and development tax credits |
|
(947) |
|
|
3.0 |
% |
| Changes in valuation allowances |
|
9,101 |
|
|
(29.0) |
% |
|
|
|
|
|
| Nontaxable or nondeductible items |
|
|
|
|
| Stock-based compensation |
|
485 |
|
|
(1.6) |
% |
| Unrealized gain on derivatives |
|
(316) |
|
|
1.0 |
% |
| Other |
|
106 |
|
|
(0.3) |
% |
| Changes in unrecognized tax benefits |
|
203 |
|
|
(0.7) |
% |
| Other |
|
|
|
|
| Prior period adjustments |
|
1,566 |
|
|
(5.0) |
% |
| Other |
|
337 |
|
|
(1.1) |
% |
| Effective tax rate |
|
$ |
6,392 |
|
|
(20.4) |
% |
The following table presents the required disclosures prior to our adoption of ASU 2023-09 and provides a reconciliation of the statutory federal income tax rate to our effective tax rate for the years ended March 31, 2025 and 2024:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended March 31, |
|
|
|
|
2025 |
|
2024 |
| Statutory federal income tax rate |
|
|
|
$ |
(18,518) |
|
|
$ |
(85,077) |
|
| State income taxes, net of federal benefit |
|
|
|
(2,591) |
|
|
— |
|
| State rate remeasurement |
|
|
|
523 |
|
|
1,680 |
|
| Nondeductible expenses |
|
|
|
— |
|
|
176 |
|
| Disallowed executive compensation |
|
|
|
2,018 |
|
|
1,145 |
|
| Excess deductions for stock-based compensation |
|
|
|
1,572 |
|
|
2,783 |
|
|
|
|
|
|
|
|
| Foreign rate differential |
|
|
|
(5,049) |
|
|
(544) |
|
|
|
|
|
|
|
|
| Impairment of goodwill |
|
|
|
— |
|
|
64,346 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Research and development tax credit |
|
|
|
(1,721) |
|
|
(721) |
|
| Change in uncertain tax liability |
|
|
|
364 |
|
|
144 |
|
| Change in valuation allowance |
|
|
|
29,551 |
|
|
29,010 |
|
| Return to provision adjustments |
|
|
|
(1,976) |
|
|
2,375 |
|
| Other miscellaneous |
|
|
|
62 |
|
|
— |
|
| Income tax expense |
|
|
|
$ |
4,235 |
|
|
$ |
15,317 |
|
|
| Summary of Valuation Allowance |
The following table represents the roll forward of our valuation allowance:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended March 31, |
|
2026 |
|
2025 |
|
2024 |
| Balance at the beginning of the year |
$ |
85,403 |
|
|
$ |
55,852 |
|
|
$ |
26,842 |
|
| Valuation allowance charged to income tax expense |
21,589 |
|
|
29,551 |
|
|
29,010 |
|
| Balance at the end of the year |
$ |
106,992 |
|
|
$ |
85,403 |
|
|
$ |
55,852 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Schedule of Cash Paid for Income Taxes |
Supplemental cash flow information related to our leases was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended March 31, |
|
2026 |
|
2025 |
|
2024 |
Cash paid for amounts included in the measurement of operating lease liabilities |
$ |
3,783 |
|
|
$ |
3,520 |
|
|
$ |
3,443 |
|
| Right-of-use assets obtained in exchange for operating lease liabilities |
1,477 |
|
|
4,096 |
|
|
2,683 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash paid for income taxes, net of refunds received, by jurisdiction pursuant to the disclosure requirements of ASU 2023-09 for the year ended March 31, 2026 was as follows:
|
|
|
|
|
|
|
|
|
|
|
Year Ended March 31, 2026 |
| U.S. federal |
|
$ |
— |
|
| State and local |
|
— |
|
| Foreign |
|
|
| Israel |
|
25,208 |
|
| Other foreign jurisdictions |
|
1,087 |
|
| Total foreign |
|
26,295 |
|
| Total cash taxes paid, net of refunds |
|
$ |
26,295 |
|
|
| Schedule of Deferred Tax Assets and Liabilities |
The significant components of net deferred tax balances were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
2026 |
|
2025 |
|
|
| Deferred tax assets |
|
|
|
|
|
|
| Net operating loss carry-forward |
|
$ |
101,931 |
|
|
$ |
90,177 |
|
|
|
| Stock-based compensation |
|
5,774 |
|
|
5,698 |
|
|
|
| Accrued compensation |
|
3,673 |
|
|
172 |
|
|
|
| Capitalized research and experimentation expenses |
|
— |
|
|
3,114 |
|
|
|
Disallowed interest expense |
|
27,326 |
|
|
15,963 |
|
|
|
| Other |
|
634 |
|
|
471 |
|
|
|
| Total deferred tax assets |
|
139,338 |
|
|
115,595 |
|
|
|
| Valuation allowance |
|
(106,992) |
|
|
(85,403) |
|
|
|
| Deferred tax assets, net of valuation allowance |
|
32,346 |
|
|
30,192 |
|
|
|
| Deferred tax liabilities |
|
|
|
|
|
|
| Depreciation and amortization |
|
(1,280) |
|
|
(1,310) |
|
|
|
| Capitalized research and experimentation expenses |
|
(8,151) |
|
|
— |
|
|
|
| Intangibles and goodwill |
|
(38,733) |
|
|
(45,190) |
|
|
|
|
|
|
|
|
|
|
| Total deferred tax liabilities |
|
(48,164) |
|
|
(46,500) |
|
|
|
| Deferred tax liabilities, net |
|
$ |
(15,818) |
|
|
$ |
(16,308) |
|
|
|
|
| Schedule of Operating Loss Carryforwards |
The following details the scheduled expiration dates of the Company’s net operating loss (NOL) carryforwards as of March 31, 2026:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2027 Through 2036 |
|
2037 Through 2046 |
|
Indefinite |
|
Total |
| U.S. federal |
|
$ |
— |
|
|
$ |
37,357 |
|
|
$ |
99,020 |
|
|
$ |
136,377 |
|
| State and local |
|
12,459 |
|
|
150,836 |
|
|
4,282 |
|
|
167,577 |
|
| Foreign |
|
927 |
|
|
702 |
|
|
210,097 |
|
|
211,726 |
|
| Total net operating loss carryforwards |
|
$ |
13,386 |
|
|
$ |
188,895 |
|
|
$ |
313,399 |
|
|
$ |
515,680 |
|
|
| Schedule of Reconciliation of Beginning and Ending Amount of Unrecognized Tax Benefits |
A reconciliation of the beginning and ending amounts of unrecognized tax benefits for the years ended March 31, 2026, 2025, and 2024, is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended March 31, |
| |
|
2026 |
|
2025 |
|
2024 |
| Balance at the beginning of the year |
|
$ |
2,532 |
|
|
$ |
2,168 |
|
|
$ |
2,024 |
|
| Additions for tax positions of prior years |
|
189 |
|
|
364 |
|
|
144 |
|
|
|
|
|
|
|
|
| Balance at the end of the year |
|
$ |
2,721 |
|
|
$ |
2,532 |
|
|
$ |
2,168 |
|
|